About HOLOCLARA, INC.
Holoclara is a biotechnology company focused on developing novel therapeutics derived from symbiotic organisms to modulate inflammation, metabolism, and tissue regeneration, aiming to address chronic disease, resilience, and aging. The company's mission is to restore missing components of the human molecular legacy by leveraging the beneficial components of intestinal worms without reintroducing live worms.
Development of drugs from organisms that modulate multiple biological networks simultaneouslyResearch in symbiotic organism-derived therapeutics for inflammation, metabolism, and tissue regenerationPreclinical development and immunology researchComputational biology and in vivo/in vitro immunology assay developmentTranslation of scientific research into robust preclinical models
Is this your company?
Claim this profile to keep it accurate — and see the federal & state opportunities GovIntel's AI has matched to HOLOCLARA, INC. right now.
Claim this profile See matched opportunitiesData compiled from public government sources including SAM.gov, USAspending.gov, and state procurement records. Last verified against federal award records. Inaccurate? Let us know.